Repeat prostate evaluation and therapy pilot study in patients undergoing high dose rate brachytherapy for prostate cancer
Not Applicable
Completed
- Conditions
- Prostate CancerCancer - Prostate
- Registration Number
- ACTRN12610001076066
- Lead Sponsor
- Peter MacCallum Cancer Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 13
Inclusion Criteria
Patients undergoing high dose rate brachytherapy for prostate cancer
Exclusion Criteria
previous transurethral resection of prostate (TURP), anticoagulation, previous sepsis from prostate biopsy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method nacceptable Toxicity Rate - a composite measure of infection (requiring >5 days of antibiotics), patient tolerance (refusal of subsequent biopsy) and grade 3 toxicity (using NCI CTC criteria)[6 weeks following intervention completion]
- Secondary Outcome Measures
Name Time Method presence of prostate tissue on each biopsy assessed using light microscopy[6 weeks following intervention completion]